Skip to content
2000
Volume 21, Issue 6
  • ISSN: 1573-4048
  • E-ISSN: 1875-6581

Abstract

Introduction

Infertility is an important issue in reproductive health. In the field of reproductive medicine, Fertilization (IVF) stands out as a central approach to helping infertile couples. Pregnancy-associated Plasma Protein-A (PAPP-A) levels increase progressively throughout pregnancy until delivery. Therefore, the present study aimed to conduct a detailed examination and comparison of PAPP-A levels between women who have undergone IVF treatment due to infertility and those with natural pregnancies, all of whom have been referred to the Gynecology and Infertility Clinic of Besat Hospital in 2020.

Methods

The present case-control study was conducted on women with IVF-induced pregnancies and those with physiological pregnancies who have been referred to the Gynecology and Infertility Clinic of Besat Hospital in 2020. Pregnant women who did not have a complete medical record and had a history of other diseases were excluded from the study. In this study, venous blood was collected from the pregnant women, and the serum level of the PAPP-A marker was checked. This information was recorded in their medical records and then subjected to statistical analysis.

Results

For this purpose, 28 pregnant women by IVF and 34 physiological pregnant women were included in the study. There was a significant relationship between the type of pregnancy (IVF and physiological pregnancy) and the serum level of PAPP-A dispersion based on the KID test, and 70.59% of pregnancies were physiological at the level of 0.5-0.9. Based on the results of the ROC curve test, the cut-off point of the serum level of PAPP-A in pregnancy caused by IVF and physiological pregnancy was 0.63. This means that in 90.91% of people whose serum level of PAPP-A was less than 0.63, the method of pregnancy was IVF.

Conclusion

The results of the present study have revealed the serum level of PAPP-A to be different depending on the type of pregnancy, and it has been found to be significantly higher in pregnant women with physiological pregnancy than in pregnancy due to IVF.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cwhr/10.2174/0115734048321126241111112215
2025-01-02
2025-10-30

  • From This Site

    /content/journals/cwhr/10.2174/0115734048321126241111112215
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. AbebeM.S. AfeworkM. AbaynewY. Primary and secondary infertility in Africa: Systematic review with meta-analysis.Fertil. Res. Pract.2020612010.1186/s40738‑020‑00090‑3 33292584
     [Google Scholar]
  2. Infertility prevalence estimates, 1990–2021.2023Available from: https://www.who.int/publications/i/item/978920068315
    [Google Scholar]
  3. AbangahG.H. RashidianT. Parizad NasirkandyM. AzamiM. A meta-analysis of the prevalence and etiology of infertility in Iran.Int. J. Fertil. Steril.2023173160173 37183842
     [Google Scholar]
  4. HolleyS.R. PaschL.A. DomarA.D. Dealing with the emotional distress following failed IVF. In:Assisted Reproduction Techniques: Challenges and Management Options. SharifK. CoomarasamyA. Wiley202110.1002/9781119622215.ch107
     [Google Scholar]
  5. InhornM.C. PatrizioP. Infertility around the globe: New thinking on gender, reproductive technologies and global movements in the 21st century.Hum. Reprod. Update201521441142610.1093/humupd/dmv016 25801630
     [Google Scholar]
  6. RamalingamM. DurgadeviP. MahmoodT. In vitro fertilization.Obstetrics, Gynaecol. Reprod. Med.201626720020910.1016/j.ogrm.2016.05.006
     [Google Scholar]
  7. LanesA. HuangT. SpragueA.E. LeaderA. PotterB. WalkerM. Maternal serum screening markers and nuchal translucency measurements in in vitro fertilization pregnancies: A systematic review.Fertil. Steril.2016106614631469.e210.1016/j.fertnstert.2016.07.1120
     [Google Scholar]
  8. ParveenN. SubhakumariK.N. KrishnanS. Pregnancy associated plasma protein-A (PAPP-A) levels in acute coronary syndrome: A case control study in a tertiary care centre.Indian J. Clin. Biochem.201530215015410.1007/s12291‑014‑0421‑9 25883421
     [Google Scholar]
  9. YanachkovaV. StaynovaR. StankovaT. KamenovZ. Placental growth factor and pregnancy-associated plasma protein - A as potential early predictors of gestational diabetes mellitus.Medicina (Kaunas)202359239810.3390/medicina59020398 36837599
     [Google Scholar]
  10. ConoverC.A. Key questions and answers about pregnancy-associated plasma protein-A.Trends Endocrinol. Metab.201223524224910.1016/j.tem.2012.02.008 22463950
     [Google Scholar]
  11. LawrenceJ.B. OxvigC. OvergaardM.T. Sottrup-JensenL. GleichG.J. HaysL.G. YatesJ.R. ConoverC.A. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A.Proc. Natl. Acad. Sci. USA19999663149315310.1073/pnas.96.6.3149 10077652
     [Google Scholar]
  12. KirkegaardI. UldbjergN. OxvigC. Biology of pregnancy‐associated plasma protein‐A in relation to prenatal diagnostics: An overview.Acta Obstet. Gynecol. Scand.20108991118112510.3109/00016349.2010.505639 20804336
     [Google Scholar]
  13. AhmadiA. GharipourM. NavabiZ.S. HeydariH. Risk factors of congenital heart diseases: A hospital-based case-control study in Isfahan, Iran.ARYA Atheroscler.202016116 32499825
     [Google Scholar]
  14. WangY. SunY. DiW. KuangY. XuB. Association between induced abortion history and later in vitro fertilization outcomes.Int. J. Gynaecol. Obstet.2018141332132610.1002/ijgo.12481 29508914
     [Google Scholar]
  15. ZouL. HongM. DaiZ. ZhuJ. PengQ. WangW. The association between previous induced abortion and in vitro fertilization outcomes: A retrospective cohort study in Hefei, China.Eur. J. Obstet. Gynecol. Reprod. Biol.202126212412810.1016/j.ejogrb.2021.05.020 34015639
     [Google Scholar]
  16. ScocciaB. DemirH. KangY. FierroM.A. WinstonN.J. in vitro fertilization pregnancy rates in levothyroxine-treated women with hypothyroidism compared to women without thyroid dysfunction disorders.Thyroid201222663163610.1089/thy.2011.0343 22540326
     [Google Scholar]
  17. MintzioriG. GoulisD.G. KolibianakisE.M. Thyroid function and IVF outcome.Curr. Opin. Obstet. Gynecol.201628319119710.1097/GCO.0000000000000263 26967594
     [Google Scholar]
  18. JenumA.K. MørkridK. SletnerL. VangeS. TorperJ.L. NakstadB. VoldnerN. Rognerud-JensenO.H. BerntsenS. MosdølA. SkrivarhaugT. VårdalM.H. HolmeI. YajnikC.S. BirkelandK.I. Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: A population-based cohort study.Eur. J. Endocrinol.2012166231732410.1530/EJE‑11‑0866 22108914
     [Google Scholar]
  19. Ganer HermanH. MaromO. KorenL. HorowitzE. SchreiberL. OkmianO. RazielA. KovoM. Gestational diabetes mellitus in in-vitro fertilization pregnancies – Clinical and placental histological characteristics.Placenta202211715616010.1016/j.placenta.2021.12.012 34902728
     [Google Scholar]
  20. ChenH. LiJ. CaiS. TangS. ZengS. ChuC. HocherC.F. RösingB. KrämerB.K. HuL. LinG. GongF. HocherB. Blastocyst transfer: A risk factor for gestational diabetes mellitus in women undergoing in vitro fertilization.J. Clin. Endocrinol. Metab.20221071e143e15210.1210/clinem/dgab594 34415990
     [Google Scholar]
  21. ThomakosP. KepaptsoglouO. KorantzisA. TrouvaA. SklavounosI. TrouvasD. TaraouneN. BarretoC. ZoupasC.S. The diagnosis of gestational diabetes mellitus and its impact on in vitro fertilization pregnancies. A pilot study.J. Diabetes Complications202135610791410.1016/j.jdiacomp.2021.107914 33773900
     [Google Scholar]
  22. GuiJ. LingZ. HouX. FanY. XieK. ShenR. In vitro fertilization is associated with the onset and progression of preeclampsia.Placenta202089505710.1016/j.placenta.2019.09.011 31675490
     [Google Scholar]
  23. GiorgettiC. Vanden MeerschautF. De RooC. SaunierO. QuarelloE. HairionD. PenarandaG. Chabert-OrsiniV. De SutterP. Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies.Hum. Reprod.201328102636264210.1093/humrep/det295 23887070
     [Google Scholar]
  24. KaganK.O. WrightD. SpencerK. MolinaF.S. NicolaidesK.H. First‐trimester screening for trisomy 21 by free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A: Impact of maternal and pregnancy characteristics.Ultrasound Obstet. Gynecol.200831549350210.1002/uog.5332 18432600
     [Google Scholar]
  25. BatsonR.J. MillsB.B. NagyZ. RoudebushW. Pregnancy-associated plasma protein A (PAPP-A):A biomarker for the aid in risk stratification of nonviable pregnancy.Fertil. Steril.20151043e35110.1016/j.fertnstert.2015.07.1092
     [Google Scholar]
  26. XiaoD. ChenhongW. YanbinX. LuZ. Gestational diabetes mellitus and first trimester pregnancy‐associated plasma protein A: A case-control study in a Chinese population.J. Diabetes Investig.20189120421010.1111/jdi.12672 28387061
     [Google Scholar]
  27. MacklonN.S. The role of artificial intelligence in embryo selection.Hum. Reprod. Update2022284474488
     [Google Scholar]
  28. MedenicaS. ZivanovicD. BatkoskaL. MarinelliS. BasileG. PerinoA. CucinellaG. GulloG. ZaamiS. The future is coming: Artificial intelligence in the treatment of infertility could improve assisted reproduction outcomes - The value of regulatory frameworks.Diagnostics (Basel)20221212297910.3390/diagnostics12122979 36552986
     [Google Scholar]
  29. CochranS.J. WilliamsA.C. ThompsonG.R. Artificial intelligence in the optimization of IVF protocols.Nat. Rev. Endocrinol.20239743244510.1038/s41574‑023‑00793‑0
     [Google Scholar]
  30. KimY. LeeJ. ParkH. AI-based psychological support for infertility patients.J. Ment. Health202231335035910.1080/09638237.2022.2084851
     [Google Scholar]
/content/journals/cwhr/10.2174/0115734048321126241111112215
Loading
Comparison of Pregnancy Associated Plasma Protein A (PAPP-A) Levels in IVF-Induced Pregnancies and Physiological Pregnancies: A Case-Control Study
Curr Womens Health Rev. 21, e15734048321126 (2025); https://doi.org/10.2174/0115734048321126241111112215
/content/journals/cwhr/10.2174/0115734048321126241111112215
/content/journals/cwhr/10.2174/0115734048321126241111112215
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): in vitro fertilization; infertility; physiological pregnancy; Pregnancy-associated plasma protein-A; Pregnancy-associated Plasma Protein-A (PAPP-A); reproductive health

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test